pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Preclinical
    UBT-48128
    Diabetes The United Laboratories International Holdings Ltd
  • Phase 1
    UBVV-111
    Chronic Lymphocytic Leukemia (CLL) Umoja BioPharma Inc
  • Phase 1
    UBX-303
    Diffuse Large B-Cell Lymphoma Ubix Therapeutics Inc
  • Phase 3
← prev
page 170 of 271
next →
Pain89
Neurology1
UGN-103
mitomycin
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…
$URGN UroGen Pharma Ltd.
  • Phase 3
    UGN-104
    mitomycin
    Transitional Cell Carcinoma (Urothelial Cell Carcinoma)$URGN UroGen Pharma Ltd.
  • ULTIVA
    ULTIVA (REMIFENTANIL HYDROCHLORIDE)
    no indication Mylan Institutional Inc
  • ULTRA-TECHNEKOW V4
    ULTRA-TECHNEKOW V4 (TECHNETIUM TC-99M)
    no indication CURIUM
  • ULTRATAG RBC
    ULTRATAG RBC (KIT FOR THE PREPARATION OF TECHNETIUM TC 99M RED BLOOD CELLS)
    no indication CURIUM
  • ULTRAVIST
    ULTRAVIST (IOPROMIDE)
    no indication BAYER HLTHCARE
  • Phase 2
    UNDC-005
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… Myra EB Systems LLC
  • UNLOXCYT
    UNLOXCYT (COSIBELIMAB-IPDL)
    1. INDICATIONS AND USAGE UNLOXCYT is indicated for the tr…$CCCC C4 Therapeutics, Inc.
  • Marketed
    Ultravate
    Ultravate (halobetasol propionate)
    Plaque Psoriasis (Psoriasis Vulgaris) Sun Pharmaceutical Industries Ltd
  • Phase 2
    Umedaptanib Pegol
    Wet (Neovascular / Exudative) Macular Degeneration Ribomic Inc
  • Preclinical
    Undisclosed
    Solid Tumor$FATE FATE THERAPEUTICS INC
  • Preclinical
    Up-284
    Glioblastoma Multiforme (GBM) Up Therapeutics LLC
  • Preclinical
    Urinary Tract Infections Program
    Urinary Tract Infections$BNTX BioNTech SE
  • Phase 2
    V-181
    Dengue Fever$MRK Merck & Co., Inc.
  • VABYSMO
    VABYSMO (FARICIMAB-SVOA)
    no indication Genentech Inc
  • Preclinical
    VAC-23
    VAC23
    Melanoma Trekka Therapeutics LLC
  • Phase 1
    VAC-85135
    Essential Thrombocythemia$JNJ JOHNSON & JOHNSON
  • VAFSEO
    VAFSEO (VADADUSTAT)
    1 INDICATIONS AND USAGE VAFSEO is indicated for the treat…$AKBA Akebia Therapeutics, Inc.
  • VALACYCLOVIR
    VALACYCLOVIR
    no indication SUN PHARM INDS LTD
  • VALGANCICLOVIR
    VALGANCICLOVIR
    no indication Ajanta Pharma Ltd
  • VALSARTAN AND HYDROCHLOROTHIAZIDE
    VALSARTAN AND HYDROCHLOROTHIAZIDE
    no indication ZYDUS LIFESCIENCES
  • Marketed
    VALTREX
    VALTREX (VALACYCLOVIR HYDROCHLORIDE)
    Chicken Pox GlaxoSmithKline LLC
  • VANFLYTA
    VANFLYTA (QUIZARTINIB DIHYDROCHLORIDE)
    no indication Daiichi Sankyo Co Ltd
  • VANRAFIA
    VANRAFIA (ATRASENTAN HYDROCHLORIDE)
    1 INDICATIONS AND USAGE VANRAFIA is indicated to reduce p…$NVS NOVARTIS AG
  • Phase 1
    VAR-200
    Focal Segmental Glomerulosclerosis (FSGS)$ZVSA ZyVersa Therapeutics, Inc.
  • VARIBAR THIN LIQUID
    VARIBAR THIN LIQUID (BARIUM SULFATE)
    no indication BRACCO
  • VAROPHEN
    VAROPHEN (DICLOFENAC SODIUM AND MENTHOL, METHYL SALICYLATE)
    no indication APOTEX